Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
---|---|---|---|---|---|
11/21/2023 | -75.23% | RBC Capital | → $5 | Reiterates | Underperform → Underperform |
09/18/2023 | 23.87% | Wedbush | → $25 | Reiterates | Outperform → Outperform |
09/15/2023 | -20.72% | HSBC | → $16 | Initiates Coverage On | → Hold |
08/31/2023 | -55.41% | Morgan Stanley | $8 → $9 | Downgrades | Equal-Weight → Underweight |
08/08/2023 | -25.68% | DA Davidson | $8.5 → $15 | Maintains | Neutral |
08/08/2023 | -50.45% | Citigroup | $6 → $10 | Maintains | Sell |
08/08/2023 | -62.84% | Wolfe Research | $6 → $7.5 | Maintains | Underperform |
08/08/2023 | -20.72% | Mizuho | $14 → $16 | Maintains | Neutral |
08/08/2023 | 23.87% | Wedbush | → $25 | Reiterates | Outperform → Outperform |
08/08/2023 | 9.01% | Raymond James | $18 → $22 | Maintains | Outperform |
08/07/2023 | -50.45% | Citigroup | $6 → $10 | Maintains | Sell |
07/28/2023 | 23.87% | Wedbush | → $25 | Initiates Coverage On | → Outperform |
06/20/2023 | -10.81% | Raymond James | $15 → $18 | Downgrades | Strong Buy → Outperform |
06/12/2023 | -10.81% | B of A Securities | $13 → $18 | Maintains | Buy |
06/06/2023 | -50.45% | Goldman Sachs | $9 → $10 | Maintains | Neutral |
06/05/2023 | -30.63% | Jefferies | $10 → $14 | Maintains | Hold |
05/10/2023 | -70.27% | Citigroup | $5 → $6 | Maintains | Sell |
05/10/2023 | -45.5% | Credit Suisse | → $11 | Reiterates | → Neutral |
05/09/2023 | -55.41% | Goldman Sachs | $8 → $9 | Maintains | Neutral |
05/09/2023 | -65.32% | Deutsche Bank | $6 → $7 | Maintains | Sell |
05/09/2023 | -50.45% | Jefferies | $8.5 → $10 | Maintains | Hold |
03/01/2023 | -60.36% | DA Davidson | → $8 | Initiates Coverage On | → Neutral |
02/23/2023 | -75.23% | RBC Capital | → $5 | Reiterates | → Underperform |
02/15/2023 | -45.5% | Credit Suisse | → $11 | Reiterates | → Neutral |
02/14/2023 | -60.36% | Goldman Sachs | $9 → $8 | Maintains | Neutral |
02/14/2023 | -60.36% | Mizuho | $7 → $8 | Maintains | Neutral |
02/03/2023 | -75.23% | Citigroup | → $5 | Reiterates | → Sell |
01/23/2023 | -70.27% | Deutsche Bank | $7 → $6 | Maintains | Sell |
01/18/2023 | -65.32% | Mizuho | → $7 | Initiates Coverage On | → Neutral |
01/05/2023 | -62.84% | Jefferies | $9 → $7.5 | Downgrades | Buy → Hold |
12/21/2022 | -77.7% | Wolfe Research | → $4.5 | Downgrades | Peer Perform → Underperform |
12/19/2022 | -60.36% | Morgan Stanley | $10 → $8 | Maintains | Equal-Weight |
11/11/2022 | -75.23% | Citigroup | $6 → $5 | Maintains | Sell |
11/08/2022 | -75.23% | RBC Capital | $6 → $5 | Maintains | Underperform |
11/08/2022 | -25.68% | Raymond James | $20 → $15 | Maintains | Strong Buy |
10/20/2022 | -50.45% | Morgan Stanley | $11 → $10 | Maintains | Equal-Weight |
08/09/2022 | -45.5% | Morgan Stanley | $13 → $11 | Maintains | Equal-Weight |
08/09/2022 | -70.27% | Citigroup | $7 → $6 | Maintains | Sell |
08/09/2022 | -40.54% | Jefferies | $13 → $12 | Maintains | Buy |
08/09/2022 | -60.36% | Deutsche Bank | $11 → $8 | Downgrades | Hold → Sell |
07/22/2022 | — | Monness, Crespi, Hardt | Downgrades | Buy → Neutral | |
07/21/2022 | -0.9% | Raymond James | → $20 | Initiates Coverage On | → Strong Buy |
06/23/2022 | -50.45% | Goldman Sachs | → $10 | Initiates Coverage On | → Neutral |
06/21/2022 | -35.59% | B of A Securities | → $13 | Initiates Coverage On | → Buy |
05/10/2022 | -35.59% | Morgan Stanley | $16 → $13 | Maintains | Equal-Weight |
05/10/2022 | -45.5% | Deutsche Bank | $15 → $11 | Maintains | Hold |
05/10/2022 | -65.32% | Citigroup | $10 → $7 | Maintains | Sell |
05/10/2022 | -70.27% | RBC Capital | $12 → $6 | Downgrades | Sector Perform → Underperform |
05/09/2022 | -30.63% | Piper Sandler | $16 → $14 | Maintains | Overweight |
04/22/2022 | -20.72% | Piper Sandler | $15 → $16 | Maintains | Overweight |
04/20/2022 | -40.54% | RBC Capital | $9 → $12 | Upgrades | Underperform → Sector Perform |
04/11/2022 | -0.9% | Monness, Crespi, Hardt | → $20 | Initiates Coverage On | → Buy |
03/09/2022 | -25.68% | Piper Sandler | → $15 | Initiates Coverage On | → Overweight |
03/07/2022 | -20.72% | Morgan Stanley | $24 → $16 | Upgrades | Underweight → Equal-Weight |
02/23/2022 | -50.45% | Citigroup | $13 → $10 | Maintains | Sell |
02/18/2022 | -25.68% | Deutsche Bank | $18 → $15 | Maintains | Hold |
11/16/2021 | 23.87% | Credit Suisse | → $25 | Initiates Coverage On | → Neutral |
11/10/2021 | 18.92% | Morgan Stanley | $22 → $24 | Maintains | Underweight |
11/10/2021 | -5.86% | RBC Capital | $25 → $19 | Downgrades | Sector Perform → Underperform |
11/02/2021 | 23.87% | Deutsche Bank | → $25 | Initiates Coverage On | → Hold |
08/13/2021 | 23.87% | RBC Capital | $20 → $25 | Maintains | Sector Perform |
08/13/2021 | 9.01% | Morgan Stanley | $19 → $22 | Maintains | Underweight |
04/23/2021 | 13.96% | Wolfe Research | → $23 | Initiates Coverage On | → Peer Perform |
02/17/2021 | -0.9% | Credit Suisse | $17 → $20 | Maintains | Underperform |
02/17/2021 | -5.86% | Morgan Stanley | $17 → $19 | Maintains | Underweight |
02/17/2021 | — | William Blair | Downgrades | Market Perform → Underperform | |
02/17/2021 | 68.47% | Goldman Sachs | $13 → $34 | Upgrades | Neutral → Buy |
01/20/2021 | — | William Blair | Initiates Coverage On | → Market Perform | |
01/13/2021 | -25.68% | Citigroup | $10 → $15 | Downgrades | Neutral → Sell |
12/18/2020 | -15.77% | Credit Suisse | → $17 | Downgrades | Neutral → Underperform |
12/02/2020 | -15.77% | Morgan Stanley | → $17 | Downgrades | Equal-Weight → Underweight |
11/13/2020 | -25.68% | Morgan Stanley | → $15 | Downgrades | Overweight → Equal-Weight |
10/26/2020 | -35.59% | Morgan Stanley | → $13 | Initiates Coverage On | → Overweight |
10/26/2020 | -50.45% | Goldman Sachs | → $10 | Initiates Coverage On | → Neutral |
10/26/2020 | — | Credit Suisse | Initiates Coverage On | → Neutral | |
10/26/2020 | -35.59% | Jefferies | → $13 | Initiates Coverage On | → Buy |
10/26/2020 | -45.5% | RBC Capital | → $11 | Initiates Coverage On | → Sector Perform |
What is the target price for Palantir Technologies (PLTR)?
The latest price target for Palantir Technologies (NYSE: PLTR) was reported by RBC Capital on November 21, 2023. The analyst firm set a price target for $5.00 expecting PLTR to fall to within 12 months (a possible -75.23% downside). 32 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Palantir Technologies (PLTR)?
The latest analyst rating for Palantir Technologies (NYSE: PLTR) was provided by RBC Capital, and Palantir Technologies reiterated their underperform rating.
When is the next analyst rating going to be posted or updated for Palantir Technologies (PLTR)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Palantir Technologies, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Palantir Technologies was filed on November 21, 2023 so you should expect the next rating to be made available sometime around November 21, 2024.
Is the Analyst Rating Palantir Technologies (PLTR) correct?
While ratings are subjective and will change, the latest Palantir Technologies (PLTR) rating was a reiterated with a price target of $0.00 to $5.00. The current price Palantir Technologies (PLTR) is trading at is $20.18, which is out of the analyst's predicted range.